Jeena sikho lifecare Limited has filed its quarterly compliance certificate with the National Stock Exchange of India Limited and BSE Limited for the quarter ended March 31, 2026. The submission fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations 2018.

Regulatory Compliance Filing

The company submitted the certificate dated April 1, 2026, to both stock exchanges on April 3, 2026. Managing Director Manish Grover (DIN: 07557886) signed the compliance documents on behalf of Jeena Sikho Lifecare Limited from the company's registered office in Zirakpur, Punjab.

Share Transfer Agent Confirmation

Skyline Financial Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate. The certificate confirms that no physical share certificates were received for dematerialization of equity shares during the quarter ended March 31, 2026.

Stock Exchange Submissions

The compliance documents were simultaneously submitted to both major Indian stock exchanges where the company's shares are listed. The National Stock Exchange received the filing under symbol JSLI, while BSE received it under scrip code 544476.

Company Information

Jeena Sikho Lifecare Limited operates with its registered office in Zirakpur, Punjab, and corporate office in New Delhi. The company's CIN number is L52601PB2017PLC046545, and it maintains operations across multiple Ayurveda clinics and hospitals as indicated in its business description.

Jeena Sikho Lifecare Limited has announced the publication of three academic papers in the International Journal of Advanced Research (IJAR), showcasing the company's commitment to evidence-based Ayurvedic research and clinical practice. The company informed stock exchanges about these publications under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Published Research Papers

The three publications authored by medical professionals associated with Jeena Sikho Lifecare Limited include the Managing Director, senior consultants, and Ayurvedic experts. These research papers demonstrate the company's ongoing dedication to advancing Ayurvedic medicine through documented clinical evidence.

Research Significance

These publications in the International Journal of Advanced Research highlight the company's approach to integrating traditional Ayurvedic principles with modern clinical documentation. The case studies and reports cover critical health conditions including chronic liver disease, chronic kidney disease, and prostatomegaly, demonstrating the therapeutic effectiveness of Ayurvedic treatments.

The research papers showcase various Ayurvedic treatment methodologies including Nidan Parivarjan (cause avoidance), Ahar (dietary modifications), Vihar (lifestyle changes), and Shaman Chikitsa (therapeutic treatments). This comprehensive approach reflects the company's holistic treatment philosophy.

Company Profile

Jeena Sikho Lifecare Limited operates over 120 Ayurveda clinics and hospitals, focusing on providing freedom from diseases and drugs through traditional Ayurvedic medicine. The company maintains its registered office in Zirakpur, Punjab, and corporate office in New Delhi, with a mission centered on "Health | Wealth | Happiness."

The publication of these research papers reinforces the company's position in evidence-based Ayurvedic healthcare and its commitment to advancing traditional medicine through scientific documentation and peer-reviewed research.